Abide: Bible Prayer Meditation vs e-Sword LT: Bible Study to Go
Revenue, downloads, ratings and category context for two iOS apps. Figures are estimates and should be read as ranges, not exact totals.
Abide: Bible Prayer MeditationGuideposts - Reference
e-Sword LT: Bible Study to GoRick Meyers - Reference| Metric | Abide: Bible Prayer Meditation | e-Sword LT: Bible Study to Go | Readout |
|---|---|---|---|
| Estimated revenue / mo | $*** - opens with trial | $*** - opens with trial | Abide: Bible Prayer Meditation |
| Revenue band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Estimated downloads / mo | $*** - opens with trial | $*** - opens with trial | Abide: Bible Prayer Meditation |
| Download band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Rating | 4.87 | 4.84 | Abide: Bible Prayer Meditation |
| Rating count | 122k | 7.0k | Abide: Bible Prayer Meditation |
| Tracked keywords | 1 | — | Abide: Bible Prayer Meditation |
| Category | Reference | Reference | Same market |
Which app is bigger?
Abide: Bible Prayer Meditation and e-Sword LT: Bible Study to Go are compared inside Reference with monthly revenue, downloads, rating, review volume, keyword footprint, category placement and range context. Abide: Bible Prayer Meditation leads on monthly downloads in the current readout, and Abide: Bible Prayer Meditation wins the revenue readout (the exact figures open with the paid plan), Abide: Bible Prayer Meditation wins demand, Abide: Bible Prayer Meditation has deeper review volume, and Abide: Bible Prayer Meditation has the larger tracked keyword footprint. The better app depends on the job: choose the revenue leader when you need monetization proof, choose the download leader when reach matters, and choose the higher-rated or deeper-reviewed app when market trust is the constraint. Read both ranges rather than only the midpoint, then open the category hub and related collections to see whether this pair is an outlier or a normal category pattern.